Fluorosulfates and sulfamoyl fluorides have applications ranging from chemical biology to polymer chemistry in addition to being valuable synthetic precursors to diaryl sulfates, sulfamides and sulfamates. Synthetic methods to construct fluorosulfates and sulfamoyl fluorides have typically relied on the use of sulfuryl fluoride gas. However, the specialized equipment and additional safety precautions required for working with a toxic gas, in addition to challenges with procurement, have precluded the broad usage of sulfuryl fluoride gas.
A solid and bench-stable alternative to sulfuryl fluoride gas has been developed by Pfizer and BioDuro chemists, 4-(acetylamino)phenyl]imidodisulfuryl difluoride (AISF, 901243). AISF is a shelf-stable, crystalline reagent for the installation of the valuable SO2F functional group.
Representative Procedure: To a one-dram vial containing the phenol or amine substrate (0.4 mmol) and AISF (901243; 134 mg, 0.48 mmol, 1.2 equiv.) was added tetrahydrofuran (2 mL) followed by 1,8-diazabicyclo [5.4.0]undec-7-ene (132 µL, 0.88 mmol, 2.2 equiv.) over a period of 30 seconds. The reaction mixture was stirred at room temperature for 10 minutes and then diluted with ethyl acetate or ether and washed with either 0.5 N KHSO4 or 0.5 N HCl (2x) and brine (1x). The combined organic fraction was dried with anhydrous sodium sulfate and concentrated under reduced pressure. The crude residue was purified by silica gel flash chromatography.
Special thanks to Chris am Ende (Pfizer) and the BioDuro Team for contributing this technology spotlight!